Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BNR

Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BNR
일자시간출처헤드라인심볼기업
2024/05/3016:42GlobeNewswire Inc.Bayer and Burning Rock collaborate to increase patient access to precision cancer medicinesNASDAQ:BNRBurning Rock Biotech Ltd
2024/05/2919:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2024/05/2914:34GlobeNewswire Inc.Burning Rock Reports First Quarter 2024 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
2024/05/2315:00GlobeNewswire Inc.Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024NASDAQ:BNRBurning Rock Biotech Ltd
2024/05/1419:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2024/05/1415:02GlobeNewswire Inc.Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024NASDAQ:BNRBurning Rock Biotech Ltd
2024/04/2916:30GlobeNewswire Inc.Burning Rock Publishes 2023 Annual Report on Form 20-FNASDAQ:BNRBurning Rock Biotech Ltd
2024/04/2614:59GlobeNewswire Inc.Burning Rock Announces ADS Ratio ChangeNASDAQ:BNRBurning Rock Biotech Ltd
2024/03/2906:16GlobeNewswire Inc.Burning Rock Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
2024/02/1502:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BNRBurning Rock Biotech Ltd
2024/01/1106:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BNRBurning Rock Biotech Ltd
2024/01/0420:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2024/01/0415:03GlobeNewswire Inc.Burning Rock Announces Receipt of Notification from NASDAQNASDAQ:BNRBurning Rock Biotech Ltd
2023/12/2020:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2023/12/2011:35GlobeNewswire Inc.Burning Rock Announces Results of 2023 Annual General MeetingNASDAQ:BNRBurning Rock Biotech Ltd
2023/11/3020:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2023/11/3015:25GlobeNewswire Inc.Burning Rock Reports Third Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
2023/11/2220:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2023/11/2216:04GlobeNewswire Inc.Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023NASDAQ:BNRBurning Rock Biotech Ltd
2023/11/2110:55GlobeNewswire Inc.Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023NASDAQ:BNRBurning Rock Biotech Ltd
2023/10/3016:20GlobeNewswire Inc.Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion DiagnosticsNASDAQ:BNRBurning Rock Biotech Ltd
2023/10/1608:18GlobeNewswire Inc.Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection TestNASDAQ:BNRBurning Rock Biotech Ltd
2023/09/0811:43GlobeNewswire Inc.Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer CellNASDAQ:BNRBurning Rock Biotech Ltd
2023/09/0519:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
2023/08/3114:30GlobeNewswire Inc.Burning Rock Reports Second Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
2023/08/0416:27GlobeNewswire Inc.Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023NASDAQ:BNRBurning Rock Biotech Ltd
2023/06/2817:05GlobeNewswire Inc.Burning Rock Announces Resignation and Appointment of DirectorsNASDAQ:BNRBurning Rock Biotech Ltd
2023/06/0813:20GlobeNewswire Inc.Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of MedicineNASDAQ:BNRBurning Rock Biotech Ltd
2023/05/3019:18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BNRBurning Rock Biotech Ltd
2023/05/3013:53GlobeNewswire Inc.Burning Rock Reports First Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
 검색 관련기사 보기:NASDAQ:BNR